Literature DB >> 23658321

Celecoxib enhances radiosensitivity of hypoxic glioblastoma cells through endoplasmic reticulum stress.

Kenshi Suzuki1, Ariungerel Gerelchuluun, Zhengshan Hong, Lue Sun, Junko Zenkoh, Takashi Moritake, Koji Tsuboi.   

Abstract

BACKGROUND: Refractoriness of glioblastoma multiforme (GBM) largely depends on its radioresistance. We investigated the radiosensitizing effects of celecoxib on GBM cell lines under both normoxic and hypoxic conditions.
METHODS: Two human GBM cell lines, U87MG and U251MG, and a mouse GBM cell line, GL261, were treated with celecoxib or γ-irradiation either alone or in combination under normoxic and hypoxic conditions. Radiosensitizing effects were analyzed by clonogenic survival assays and cell growth assays and by assessing apoptosis and autophagy. Expression of apoptosis-, autophagy-, and endoplasmic reticulum (ER) stress-related genes was analyzed by immunoblotting.
RESULTS: Celecoxib significantly enhanced the radiosensitivity of GBM cells under both normoxic and hypoxic conditions. In addition, combined treatment with celecoxib and γ-irradiation induced marked autophagy, particularly in hypoxic cells. The mechanism underlying the radiosensitizing effect of celecoxib was determined to be ER stress loading on GBM cells.
CONCLUSION: Celecoxib enhances the radiosensitivity of GBM cells by a mechanism that is different from cyclooxygenase-2 inhibition. Our results indicate that celecoxib may be a promising radiosensitizing drug for clinical use in patients with GBM.

Entities:  

Keywords:  ER stress; autophagy; celecoxib; glioblastoma; hypoxia; radiosensitivity

Mesh:

Substances:

Year:  2013        PMID: 23658321      PMCID: PMC3748914          DOI: 10.1093/neuonc/not062

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  63 in total

1.  ER stress induced by ionising radiation in IEC-6 cells.

Authors:  Bo Zhang; Yan Wang; Xueli Pang; Yongping Su; Guoping Ai; Tao Wang
Journal:  Int J Radiat Biol       Date:  2010-06       Impact factor: 2.694

2.  Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells.

Authors:  Kuan-Hsuan Chen; Chuan-Chih Hsu; Wen-Shin Song; Chi-Shuan Huang; Chia-Chen Tsai; Cheng-Deng Kuo; Han-Shui Hsu; Tung-Hu Tsai; Ching-Yao Tsai; Lin-Chung Woung; Shih-Hwa Chiou; Kai-Hsi Lu; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2010-06-05       Impact factor: 1.475

3.  Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.

Authors:  Hsin-I Ma; Shih-Hwa Chiou; Dueng-Yuan Hueng; Lung-Kuo Tai; Pin-I Huang; Chung-Lan Kao; Yi-Wei Chen; Huey-Kang Sytwu
Journal:  J Neurosurg       Date:  2010-11-05       Impact factor: 5.115

4.  Ubiquitin-recognition protein Ufd1 couples the endoplasmic reticulum (ER) stress response to cell cycle control.

Authors:  Meifan Chen; Gustavo J Gutierrez; Ze'ev A Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-13       Impact factor: 11.205

5.  Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

6.  Hypoxia-induced autophagy: cell death or cell survival?

Authors:  Nathalie M Mazure; Jacques Pouysségur
Journal:  Curr Opin Cell Biol       Date:  2009-12-21       Impact factor: 8.382

7.  Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts.

Authors:  Michio Kaneko; Setsuko Kaneko; Kenshi Suzuki
Journal:  Cancer Sci       Date:  2009-07-08       Impact factor: 6.716

8.  Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.

Authors:  James J Lee; Mitsuteru Natsuizaka; Shinya Ohashi; Gabrielle S Wong; Munenori Takaoka; Carmen Z Michaylira; Daniela Budo; John W Tobias; Michiyuki Kanai; Yasuhiro Shirakawa; Yoshio Naomoto; Andres J P Klein-Szanto; Volker H Haase; Hiroshi Nakagawa
Journal:  Carcinogenesis       Date:  2009-12-30       Impact factor: 4.944

9.  A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; Javier Gonzalez; Kathy Hunter; Kenneth Hess; Pierre Giglio; Eric Chang; Vinay Puduvalli; Morris D Groves; Howard Colman; Charles Conrad; Victor Levin; Shaio Woo; Anita Mahajan; John de Groot; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2010-08-20       Impact factor: 12.300

10.  Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy.

Authors:  Khong Bee Kang; Congju Zhu; Sook Kwin Yong; Qiuhan Gao; Meng Cheong Wong
Journal:  Mol Cancer       Date:  2009-08-25       Impact factor: 27.401

View more
  30 in total

1.  Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.

Authors:  Jingtao Zhong; Xiaofeng Dong; Peng Xiu; Fuhai Wang; Ju Liu; Honglong Wei; Zongzhen Xu; Feng Liu; Tao Li; Jie Li
Journal:  Cell Prolif       Date:  2015-10-20       Impact factor: 6.831

2.  Fluorescent flavonoids for endoplasmic reticulum cell imaging.

Authors:  Lucas McDonald; Bin Liu; Alexandra Taraboletti; Kyle Whiddon; Leah P Shriver; Michael Konopka; Qin Liu; Yi Pang
Journal:  J Mater Chem B       Date:  2016-11-23       Impact factor: 6.331

3.  Association of collagen architecture with glioblastoma patient survival.

Authors:  Kelli B Pointer; Paul A Clark; Alexandra B Schroeder; M Shahriar Salamat; Kevin W Eliceiri; John S Kuo
Journal:  J Neurosurg       Date:  2016-09-02       Impact factor: 5.115

4.  Stressed Out - Therapeutic Implications of ER Stress Related Cancer Research.

Authors:  Randal Riha; Pooja Gupta-Saraf; Payel Bhanja; Samyak Badkul; Subhrajit Saha
Journal:  Oncomedicine       Date:  2017-09-27

5.  Celecoxib enhances the radiosensitivity of HCT116 cells in a COX-2 independent manner by up-regulating BCCIP.

Authors:  Xiao-Ting Xu; Wen-Tao Hu; Ju-Ying Zhou; Yu Tu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.

Authors:  Yi-Hsien Chen; Lucy D'Agostino McGowan; Patrick J Cimino; Sonika Dahiya; Jeffrey R Leonard; Da Yong Lee; David H Gutmann
Journal:  Cell Rep       Date:  2015-03-12       Impact factor: 9.423

7.  Exploring the inverse association of glioblastoma multiforme and Alzheimer's disease via bioinformatics analysis.

Authors:  Jiayang Cai; Liguo Ye; Yuanyuan Hu; Zhang Ye; Lun Gao; Yixuan Wang; Qian Sun; Shiao Tong; Ji'an Yang; Qianxue Chen
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

8.  Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.

Authors:  Peter J Cook; Rozario Thomas; Philip J Kingsley; Fumiko Shimizu; David C Montrose; Lawrence J Marnett; Viviane S Tabar; Andrew J Dannenberg; Robert Benezra
Journal:  Neuro Oncol       Date:  2016-03-28       Impact factor: 12.300

9.  Celecoxib and LLW-3-6 Reduce Survival of Human Glioma Cells Independently and Synergistically with Sulfasalazine.

Authors:  Tokunbo Yerokun; Leyte L Winfield
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

10.  Celecoxib suppresses the phosphorylation of STAT3 protein and can enhance the radiosensitivity of medulloblastoma-derived cancer stem-like cells.

Authors:  Meng-Yin Yang; Hsu-Tung Lee; Chien-Min Chen; Chiung-Chyi Shen; Hsin-I Ma
Journal:  Int J Mol Sci       Date:  2014-06-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.